NCT06931158View on ClinicalTrials.gov

HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain

NARecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Chronic Low-back PainChronic Pain
Interventions
DRUG

Open-label Placebo

Open-label placebo pill for 21 days at 2 per day

BEHAVIORAL

Standard Rationale

Scientific rationale about the placebo effect

BEHAVIORAL

Mindfulness

Mindfulness based rationale

BEHAVIORAL

Control Rationale

Basic epidemiological information about chronic pain to achieve structural equivalence for the control groups

Trial Locations (1)

02906

RECRUITING

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Rhode Island Hospital

OTHER